Volume 10,Issue 3
Treatment, Intervention and Improvement of Psychosocial Adaptation in Patients with Chronic Urticaria —— Empirical Evidence from China
Objective: This study aimed to evaluate the effectiveness of a comprehensive intervention in improving biological indicators and psychosocial adaptation in patients with chronic urticaria. Methods: One hundred patients with chronic urticaria were randomly assigned to an experimental group and a control group. All patients received standard physiological interventions, while the experimental group underwent and assessed standardized psychosocial support measures. Key outcomes included serum IgE and high-sensitivity C-reactive protein (hs-CRP) levels, as well as psychosocial adaptation assessed using the PASQ scale. Results: After two months of follow-up, the experimental group showed a significant reduction in post-treatment IgE levels to (30.95 ± 5.77) IU/mL, significantly lower than the control group's (43.42 ± 5.94) IU/mL (t = 9.71, p = 0.001). Similarly, the experimental group's hs-CRP levels also decreased significantly to (9.62 ± 2.13) mg/L, lower than the control group's (12.12 ± 2.38) mg/L (t = 5.04, p = 0.001). Psychosocial function evaluations revealed that the experimental group scored significantly higher than the control group in emotional dimension (37.84 ± 2.48), self-perception dimension (28.40 ± 1.62), and social dimension (18.92 ± 1.18) after treatment (p <0.001). Conclusion: This intervention demonstrated significantly better outcomes than conventional approaches in regulating allergic immune responses, managing systemic inflammation, and enhancing psychosocial resilience among patients with chronic urticaria. These findings underscore the value of implementing comprehensive strategies in chronic urticaria management, highlighting the critical importance of integrating biological, psychological, and social dimensions in therapeutic approaches.
[1] Konstantinou G N, 2019, Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis//Clinical and Translational Allergy. 9: Article 52.
[2] Ulusoy Ş, Şahin R, 2022, Depression, anxiety, stress and life satisfaction in patients with chronic spontaneous urticaria. Annals of Medical Research, 29(12): 1342–1348.
[3] Donnelly J, Ridge K, O’Donovan R, et al., 2023, Psychosocial factors and chronic spontaneous urticaria: a systematic review//BMC Psycholog. 11: Article 291.
[4] Śmierciak N, 2023, Unraveling the complex nexus of chronic spontaneous urticaria: Immunological, infectious and psychosomatic dimensions. Psychology & Psychological Research International Journal, 8(3): 1–10.
[5] Zhang X, Xu H, Feng L, et al., 2021, Exploring psychosocial adaptation among people with chronic skin disease: A grounded theory study. Nursing Open, 8(5): 2673–2685.
[6] Tomaszewska K, Słodka A, Tarkowski B, et al., 2023, Neuro–immuno–psychological aspects of chronic urticaria. Journal of Clinical Medicine, 12(4): Article 1391.
[7] Jerković H, Bešlić I, Ćesić D, et al., 2021, The psychosocial burden of urticaria. Rad Hrvatske Akademije Znanosti i Umjetnosti. Medicinske Znanosti, 56–57, 98–103.
[8] Grattan C, Zuberbier T, Maurer M. Other Interventions for Chronic Urticaria//Urticaria and Angioedema. 2021: 177-206.
[9] Li S, Chen A, 2025, Validation of the Reliability and Validity of PSAQCSD, a Psychosocial Adaptation Assessment for Patients with Chronic Urticaria. Dermatological Health, 3(2): 1-10.
[10] Karstarli B O S, Demir B, Cicek D, et al., 2023, In chronic spontaneous urticaria, IgE and C‐reactive protein are linked to distinct microRNAs and interleukin‐31//Clinical and Translational Allergy. 13(2): Article e12215.
[11] Ghazanfar M N, Sørensen J A, Zhang D, et al., 2023, Occurrence and risk factors of mental disorders in patients with chronic urticaria//World Allergy Organization Journal. 16(1): Article 100742.
[12] Chen J, 2019, Changes in Immune-inflammatory Related Indicators and Plasma Dimer Levels in Chronic Urticaria and Correlation Analysis. China Journal of Modern Drug Application, 13(19): 52-54.
[13] Magen E, Chikovani T, Waitman D A, et al., 2019, Factors related to omalizumab resistance in chronic spontaneous urticaria. Allergy and Asthma Proceedings, 40(4): 273–278.
[14] Liu K, Zhang S Y, Wang R, et al., 2024, Research Advances in Psychosomatic Intervention for Chronic Urticaria. Journal of the PLA Medical University, 45(09):996-999+1005.
[15] Tawil S, Irani C, Kfoury R, et al., 2023, Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study[Z]//Acta Dermato-Venereologica.103: Article adv00882.
[16] Gyawalee M, Paudel V, 2023, Socio-demographic and clinical characteristics of chronic urticaria among patients attending Dermatology Clinic in a Tertiary Care Hospital. Our Dermatology Online, 14(2): 240–248.
[17] Zuberbier T, Abdul L A H, Abuzakouk M, et al., 2022, The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy, 77(3): 734–766.